Furey Raymond J. — SEC Form 4 filings
SEC reporting owner CIK 1577899. 12 Form 4 filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-25 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 2,787 shares, $59,653 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 1,448 shares @ $20.92 ($30,294) in RIGEL PHARMACEUTICALS INC, filed 2025-02-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RIGEL PHARMACEUTICALS INC (RIGL) | EVP, GC, CCO & Corp Sec | 12 | — | 2 legs · 2,787 sh · $59,653 | 15 |
Form 4 filings — Furey Raymond J.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 877 @ $47.50 | EDGAR |
| 2026-06-22 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 7,394 (derivative) @ $0 | EDGAR |
| 2026-06-03 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 877 @ $29.86 | EDGAR |
| 2026-02-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 19,497 @ $0 | EDGAR |
| 2026-02-12 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 3,546 @ $34.62 | EDGAR |
| 2026-02-04 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Tax withholding (F): 3,968 @ $36.01 | EDGAR |
| 2025-09-17 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 7,394 (derivative) @ $0 | EDGAR |
| 2025-03-19 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 9,375 (derivative) @ $0 · Grant/award (A): 7,850 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Sale (S): 1,448 @ $20.92 · Sale (S): 1,339 @ $21.93 | EDGAR |
| 2025-01-31 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 19,717 @ $0 · Grant/award (A): 14,788 (derivative) @ $0 | EDGAR |
| 2024-03-01 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 93,750 (derivative) @ $0 · Grant/award (A): 78,500 (derivative) @ $0 | EDGAR |
| 2024-01-25 | 4 | RIGEL PHARMACEUTICALS INC (RIGL) | Grant/award (A): 209,000 @ $0 · Grant/award (A): 157,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1577899 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →